Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J9262 · per 0.01 MG

Inj, omacetaxine mep, 0.01mg

This code is not in the latest file (4Q26). It was last listed in 2Q24.

Payment limit per 0.01 MG, by effective quarter, 1Q21 to 2Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9262

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
2Q24 $3.953 −$0.007 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted March 11, 2025
1Q24 $3.96 −$0.002 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted December 19, 2024
4Q23 $3.962 −$0.045 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted October 10, 2024
3Q23 $4.007 +$0.344 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 5, 2024
2Q23 $3.663 +$0.015 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted February 23, 2024
1Q23 $3.648 +$0.002 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted December 6, 2023
4Q22 $3.646 +$0.036 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 22, 2023
3Q22 $3.61 +$0.31 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 9, 2023
2Q22 $3.30 $0.00 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted December 14, 2022
1Q22 $3.30 −$0.002 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 8, 2022
4Q21 $3.302 −$0.008 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 2, 2022
3Q21 $3.31 $0.00 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted June 2, 2022
2Q21 $3.31 −$0.002 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted March 1, 2022
1Q21 $3.312 – 0.01 MG Inj, omacetaxine mep, 0.01mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files